• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

    9/27/24 5:47:00 AM ET
    $IH
    Other Consumer Services
    Real Estate
    Get the next $IH alert in real time by email

    BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024.

    (PRNewsfoto/iHuman Inc.)

    Second Quarter 2024 Highlights

    • Revenues were RMB215.1 million (US$29.6 million), compared with RMB241.0 million in the same period last year.
    • Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year.
    • Operating income was RMB18.8 million (US$2.6 million), compared with RMB40.9 million in the same period last year.
    • Net income was RMB24.7 million (US$3.4 million), compared with RMB42.1 million in the same period last year.
    • Average total MAUs[1] for the second quarter were 24.57 million, a year-over-year increase of 20.8%.

    [1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

    Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "In the second quarter, we made steady progress in advancing our strategic priorities, intensifying efforts across multiple fronts to build momentum for our sustainable growth.

    In the domestic market, we expanded our smart device lineup with the introduction of the iHuman Pinyin Reader, which is designed to help kids master Pinyin through high-quality content, interactive hands-on experiences, and engaging exercises. The product features catchy pinyin mnemonics to enhance memory retention and offers audio and visual challenges to make learning more engaging. The iHuman Pinyin Reader uses Pinyin as a gateway to introduce nursery rhymes and foundational Chinese classical studies. Its proprietary rating system also assigns children to different proficiency levels, keeping kids motivated while making it easy for parents to track progress.

    Our international expansion continued to gain momentum as we enriched our content library with new themes that appeal to young audiences worldwide. In Aha Makeover, we launched "Mermaid Melody" and "Forest Fantasy," two themes that combine imaginative elements like whimsical mermaids and enchanting forests with a variety of interactive features. In Gogo Mini World, the new theme "Fashion Salon" offers a dynamic platform for creative expression through beauty and styling activities, allowing children to share photos of their unique fashion designs. Furthermore, the new theme "Princess Castle" introduces a magical touch with magic wand play and customizable fireworks. These new themes are particularly engaging for children as they offer a mix of fantasy, creativity, and interactive fun, encouraging them to explore their interests and unleash their imaginations.

    During the quarter, our animation studio Kunpeng also made notable headway internationally with its Cosmicrew franchise. Following a successful run on major TV networks and streaming platforms in China, the Cosmicrew animated series has now expanded into several global markets, including the United States, the United Kingdom, Australia, and Singapore. The franchise's international reach was further extended with the Cosmicrew movie, which, after its premiere in China in 2023, has also been screened this year in several European countries. This global expansion not only boosts Kunpeng's international visibility and brand recognition, but also supports our broader international business strategy, thereby solidifying our presence in key global markets.

    The progress we achieved across markets and business lines in the second quarter underscores our effective execution and commitment to long-term growth. Moving forward, we will continue to build on core strengths and leverage our extensive product portfolio to drive market expansion and business growth," concluded Dr. Dai.

    Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "In the second quarter of 2024, we recorded our tenth consecutive quarter of profitability. We also ended the quarter with RMB1.13 billion in cash, cash equivalents, and time deposits. With our healthy financial position, we have the privilege to accelerate our innovation efforts in pioneering content and technologies, ensuring that we remain at the forefront of technological developments and emerging trends to welcome and accommodate the evolving needs and preferences of users. For instance, during the quarter, we developed an experimental product specifically designed for use with Apple's Vision Pro, establishing ourselves as an industry pioneer in exploring applications compatible with this revolutionary headset. By harnessing the Vision Pro's immersive spatial environment, precise eye tracking, and gesture capture functions, we deliver even more interactive and captivating experiences for children. On the operational front, we calibrated our sales and marketing efforts to align with our expanded efforts on new product development and launches. Notably, we have strengthened collaborations with leading manufacturers of learning pads, smart speakers, tablets, and even smart cars to pre-install our app products. As smart devices become increasingly integral to daily life, we expect these partnerships to extend our market coverage and make our offerings more accessible to families. Looking ahead to the second half of the year, we will continue to invest strategically in product innovation and global brand recognition to build a sustainable growth engine for our business."

    Second Quarter 2024 Unaudited Financial Results

    Revenues

    Revenues were RMB215.1 million (US$29.6 million), a decrease of 10.7% from RMB241.0 million in the same period last year, primarily due to more conservative consumer spending.

    Average total MAUs for the quarter were 24.57 million, an increase of 20.8% year-over-year from 20.33 million in the same period last year, primarily due to the effective execution of our user acquisition strategy.

    Cost of Revenues

    Cost of revenues was RMB63.4 million (US$8.7 million), a decrease of 9.7% from RMB70.2 million in the same period last year, primarily due to decreased channel costs.

    Gross Profit and Gross Margin

    Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year. Gross margin was 70.5%, compared with 70.9% in the same period last year.

    Operating Expenses

    Total operating expenses were RMB132.9 million (US$18.3 million), compared to RMB130.0 million in the same period last year.

    Research and development expenses were RMB57.2 million (US$7.9 million), a decrease of 9.8% from RMB63.4 million in the same period last year, primarily due to decreased payroll related expenses.  

    Sales and marketing expenses were RMB51.3 million (US$7.1 million), an increase of 26.4% from RMB40.6 million in the same period last year, primarily due to increased strategic spending on promotional activities, brand enhancement, and overseas expansion.

    General and administrative expenses were RMB24.4 million (US$3.4 million), a decrease of 6.0% from RMB26.0 million in the same period last year, primarily due to decreases in share-based compensation expenses, as well as other administrative expenses.

    Operating Income 

    Operating income was RMB18.8 million (US$2.6 million), compared with RMB40.9 million in the same period last year.

    Net Income 

    Net income was RMB24.7 million (US$3.4 million), compared with RMB42.1 million in the same period last year.

    Basic and diluted net income per ADS were RMB0.47 (US$0.06) and RMB0.45 (US$0.06), respectively, compared with RMB0.80 and RMB0.77 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

    Deferred Revenue and Customer Advances

    Deferred revenue and customer advances were RMB289.9 million (US$39.9 million) as of June 30, 2024, compared with RMB318.6 million as of December 31, 2023.

    Cash, Cash Equivalents and Time Deposits

    Cash, cash equivalents and time deposits were RMB1,129.4 million (US$155.4 million) as of June 30, 2024, compared with RMB1,213.8 million as of December 31, 2023. The decrease was primarily due to the payment of annual bonuses to employees in the first quarter.

    Exchange Rate Information

    The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of June 28, 2024, which was RMB7.2672 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

    Non-GAAP Financial Measures

    iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

    Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates"  and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    About iHuman Inc.

    iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

    For more information about iHuman, please visit https://ir.ihuman.com/. 

    For investor and media enquiries, please contact:

    iHuman Inc.

    Mr. Justin Zhang

    Investor Relations Director

    Phone: +86 10 5780-6606

    E-mail: [email protected] 

    Christensen

    In China

    Ms. Alice Li

    Phone: +86-10-5900-1548

    E-mail: [email protected]

    In the US

    Ms. Linda Bergkamp

    Phone: +1-480-614-3004

    E-mail: [email protected] 

     

    iHuman Inc.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS 



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    December 31,



    June 30,



    June 30,



    2023



    2024



    2024



    RMB



    RMB



    US$













    ASSETS











    Current assets











    Cash and cash equivalents 

    1,213,767



    914,474



    125,836

    Time deposits

    -



    214,944



    29,577

    Accounts receivable, net

    60,832



    52,440



    7,216

    Inventories, net

    16,518



    19,070



    2,624

    Amounts due from related parties

    1,810



    1,773



    244

    Prepayments and other current assets

    89,511



    93,971



    12,931

    Total current assets

    1,382,438



    1,296,672



    178,428

    Non-current assets











    Property and equipment, net

    6,169



    4,643



    639

    Intangible assets, net

    23,245



    20,430



    2,811

    Operating lease right-of-use assets

    3,648



    2,811



    387

    Long-term investment

    26,333



    26,333



    3,624

    Other non-current assets

    8,662



    7,981



    1,098

    Total non-current assets

    68,057



    62,198



    8,559

    Total assets

    1,450,495



    1,358,870



    186,987













    LIABILITIES











    Current liabilities











    Accounts payable

    22,139



    19,925



    2,742

    Deferred revenue and customer advances

    318,587



    289,927



    39,895

    Amounts due to related parties

    4,428



    15,164



    2,087

    Accrued expenses and other current liabilities

    143,677



    91,244



    12,556

    Dividend payable

    -



    30,653



    4,218

    Current operating lease liabilities

    1,927



    1,788



    246

    Total current liabilities

    490,758



    448,701



    61,744

    Non-current liabilities











    Non-current operating lease liabilities

    1,933



    1,083



    149

    Total non-current liabilities

    1,933



    1,083



    149

    Total liabilities

    492,691



    449,784



    61,893

    SHAREHOLDERS' EQUITY











    Ordinary shares (par value of US$0.0001 per share,

        700,000,000 Class A shares authorized as of

        December 31, 2023 and June 30, 2024; 125,122,382

        Class A shares issued and 119,704,787 outstanding as

        of December 31, 2023; 125,122,382 Class A shares

        issued and 117,852,782 outstanding as of June 30,

        2024; 200,000,000 Class B shares authorized,

        144,000,000 Class B ordinary shares issued and

        outstanding as of December 31, 2023 and June 30,

        2024; 100,000,000 shares (undesignated) authorized,

        nil shares (undesignated) issued and outstanding as of

        December 31, 2023 and June 30, 2024)

    185



    185



    25

    Additional paid-in capital

    1,088,628



    995,474



    136,982

    Treasury stock

    (16,665)



    (21,788)



    (2,998)

    Statutory reserves

    8,164



    8,164



    1,123

    Accumulated other comprehensive income

    17,955



    20,549



    2,828

    Accumulated deficit

    (140,463)



    (93,498)



    (12,866)

    Total shareholders' equity

    957,804



    909,086



    125,094

    Total liabilities and shareholders' equity

    1,450,495



    1,358,870



    186,987

     

    iHuman Inc.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    For the three months ended



    For the six months ended



    June 30,



    March 31,



    June 30,



    June 30,



    June 30,



    June 30,



    June 30,



    2023



    2024



    2024



    2024



    2023



    2024



    2024



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Revenues

    240,993



    235,003



    215,107



    29,600



    506,196



    450,110



    61,938

    Cost of revenues

    (70,160)



    (66,892)



    (63,372)



    (8,720)



    (149,796)



    (130,264)



    (17,925)





























    Gross profit

    170,833



    168,111



    151,735



    20,880



    356,400



    319,846



    44,013





























    Operating expenses



























    Research and development expenses

    (63,412)



    (67,923)



    (57,219)



    (7,874)



    (125,085)



    (125,142)



    (17,220)

    Sales and marketing expenses

    (40,564)



    (54,995)



    (51,263)



    (7,054)



    (80,999)



    (106,258)



    (14,622)

    General and administrative expenses

    (25,982)



    (27,724)



    (24,426)



    (3,361)



    (52,717)



    (52,150)



    (7,176)

    Total operating expenses

    (129,958)



    (150,642)



    (132,908)



    (18,289)



    (258,801)



    (283,550)



    (39,018)

    Operating income

    40,875



    17,469



    18,827



    2,591



    97,599



    36,296



    4,995

    Other income, net

    8,132



    9,010



    9,410



    1,295



    14,214



    18,420



    2,535

    Income before income taxes

    49,007



    26,479



    28,237



    3,886



    111,813



    54,716



    7,530

    Income tax expenses

    (6,933)



    (4,177)



    (3,574)



    (492)



    (16,093)



    (7,751)



    (1,067)

    Net income

    42,074



    22,302



    24,663



    3,394



    95,720



    46,965



    6,463





























    Net income per ADS:



























       - Basic

    0.80



    0.42



    0.47



    0.06



    1.81



    0.89



    0.12

       - Diluted

    0.77



    0.41



    0.45



    0.06



    1.75



    0.86



    0.12





























    Weighted average number of ADSs:



























       - Basic

    52,804,594



    52,729,148



    52,496,541



    52,496,541



    52,878,535



    52,612,845



    52,612,845

       - Diluted

    54,725,528



    54,691,599



    54,295,419



    54,295,419



    54,744,139



    54,493,509



    54,493,509





























    Total share-based compensation expenses included in:



























    Cost of revenues

    70



    40



    26



    4



    168



    66



    9

    Research and development expenses

    1,142



    457



    348



    48



    1,780



    805



    111

    Sales and marketing expenses

    59



    46



    45



    6



    438



    91



    13

    General and administrative expenses

    1,160



    301



    392



    54



    2,452



    693



    95





























     

    iHuman Inc.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    For the three months ended



    For the six months ended



    June 30,



    March 31,



    June 30,



    June 30,



    June 30,



    June 30,



    June 30,



    2023



    2024



    2024



    2024



    2023



    2024



    2024



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Operating income

    40,875



    17,469



    18,827



    2,591



    97,599



    36,296



    4,995

    Share-based compensation expenses

    2,431



    844



    811



    112



    4,838



    1,655



    228

    Adjusted operating income

    43,306



    18,313



    19,638



    2,703



    102,437



    37,951



    5,223





























    Net income

    42,074



    22,302



    24,663



    3,394



    95,720



    46,965



    6,463

    Share-based compensation expenses

    2,431



    844



    811



    112



    4,838



    1,655



    228

    Adjusted net income

    44,505



    23,146



    25,474



    3,506



    100,558



    48,620



    6,691





























    Diluted net income per ADS

    0.77



    0.41



    0.45



    0.06



    1.75



    0.86



    0.12

    Impact of non-GAAP adjustments

    0.04



    0.01



    0.02



    0.00



    0.09



    0.03



    0.00

    Adjusted diluted net income per ADS

    0.81



    0.42



    0.47



    0.06



    1.84



    0.89



    0.12





























    Weighted average number of ADSs – diluted

    54,725,528



    54,691,599



    54,295,419



    54,295,419



    54,744,139



    54,493,509



    54,493,509

    Weighted average number of ADSs – adjusted

    54,725,528



    54,691,599



    54,295,419



    54,295,419



    54,744,139



    54,493,509



    54,493,509

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-second-quarter-2024-unaudited-financial-results-302260944.html

    SOURCE iHuman Inc.

    Get the next $IH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IH

    DatePrice TargetRatingAnalyst
    12/30/2022$3.10Buy
    Citigroup
    More analyst ratings

    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

      SC 13G/A - iHuman Inc. (0001814423) (Subject)

      3/8/22 10:06:04 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

      SC 13G/A - iHuman Inc. (0001814423) (Subject)

      2/14/22 4:13:25 PM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form SC 13G filed

      SC 13G - iHuman Inc. (0001814423) (Subject)

      2/16/21 6:11:44 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UPDATE - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

      NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live pr

      5/8/25 10:44:07 AM ET
      $BLTE
      $COE
      $HCM
      $IH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Other Consumer Services
      Real Estate
    • International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

      NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live pr

      5/8/25 8:35:00 AM ET
      $BLTE
      $COE
      $HCM
      $IH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Other Consumer Services
      Real Estate
    • iHuman Inc. Files 2024 Annual Report on Form 20-F

      BEIJING, April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission on April 28, 2025. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements for the year ended December 31, 2024, free of charge, to its shareholders and ADS holders upon request. Requests should be directed t

      4/28/25 4:40:00 PM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    SEC Filings

    See more
    • SEC Form 20-F filed by iHuman Inc.

      20-F - iHuman Inc. (0001814423) (Filer)

      4/28/25 4:01:23 PM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by iHuman Inc.

      6-K - iHuman Inc. (0001814423) (Filer)

      3/25/25 7:10:38 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by iHuman Inc.

      6-K - iHuman Inc. (0001814423) (Filer)

      12/26/24 6:01:05 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Citigroup resumed coverage on iHuman with a new price target

      Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10

      12/30/22 8:45:58 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Financials

    Live finance-specific insights

    See more
    • iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

      BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenues were RMB232.7 million (US$31.9 million), compared with RMB250.4 million in the same period last year.Gross profit was RMB156.4 million (US$21.4 million), compared with RMB178.2 million in the same period last year.Operating income was RMB14.9 million (US$2.0 m

      3/25/25 4:03:00 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

      BEIJING, Dec. 26, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2024.   Third Quarter 2024 Highlights Revenues were RMB239.4 million (US$34.1 million), compared with RMB261.5 million in the same period last year.Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year.Operating income was RMB20.7 million (US$2.9 million), compare

      12/26/24 3:18:00 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

      BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenues were RMB215.1 million (US$29.6 million), compared with RMB241.0 million in the same period last year.Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year.Operating income was RMB18.8 million (US$2.6 million), compared wi

      9/27/24 5:47:00 AM ET
      $IH
      Other Consumer Services
      Real Estate